CONMED Corp (CNMD) Stock Price, Financials & Summary

Price chart

Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3Nov 6

Key dataNov 6, 2026

Open$51.11

From 52W high−4.03%

Volume331546.00

Market cap$1.53B

P/E (TTM)21.3x

P/S (TTM)1.1x

Div yield—

Key dataNov 6, 2026

Open

$51.11

From 52W high

−4.03%

Volume

331546.00

Market cap

$1.53B

ValuationView details →

P/E (Fwd)

11.1x

EV/EBITDA

10.9x

P/E (TTM)

21.3x

RSI (14)

62.6

MomentumView details →

1D Return

−2.52%

YTD Return

+28.13%

SummaryUpdated Sep 1, 2026

CONMED Corporation (NYSE:CNMD) is a medical technology company founded in 1970 and headquartered in Largo, Florida. The company went public in 1987 and has grown to become a significant player in the surgical device industry, developing, manufacturing, and selling surgical equipment and related products for procedures worldwide. CONMED has built its business through both organic growth and strategic acquisitions, including notable purchases of In2Bones and Biorez in 2022, which expanded its orthopedic capabilities. The company operates globally, serving hospitals, surgery centers, and other healthcare institutions directly and through medical specialty distributors.

Ask drillr about CONMED Corp →

ValuationView details →

P/E (Fwd)

11.1x

P/E (TTM)

21.3x

EV/EBITDA

10.9x

EV/Sales

1.7x

P/S (TTM)

1.1x

P/B (TTM)

1.4x

ProfitabilityView details →

Gross Margin

57.20%

Net Margin

5.36%

EBITDA Margin

15.43%

ROE (TTM)

6.93%

ROA (TTM)

3.19%

Asset Turnover

0.59x

GrowthView details →

Revenue YoY

+1.68%

EPS YoY

+17.34%

FCF YoY

−10.92%

Revenue CAGR 3Y

+9.55%

EPS CAGR 3Y

−14.92%

EBITDA YoY

+13.22%

MomentumView details →

1D Return

−2.52%

YTD Return

+28.13%

1Y Return

+18.31%

RSI (14)

62.6

vs 50D SMA

+10.60%

vs 200D SMA

+24.98%

Capital & dividendView details →

Debt/Equity

0.77x

Current Ratio

1.49x

Quick Ratio

0.70x

Div Yield

—

Div Rate

—

Div Growth 1Y

−25.00%

EarningsView details →

EPS (Actual)

$1.04

EPS Surprise

4.00%

Beats (12Q)

10/12

Next Q EPS Est

$1.26

Avg Surprise (4Q)

11.30%

Rev Surprise

−0.22%

Financials snapshotView financials →

Revenue (TTM)

1.37B

Net Income (TTM)

73.43M

Op. CF (TTM)

146.31M

Next earningsJan 27, 2027 →

Latest newsMore news →

CONMED Corp reported quarterly earnings of $1.04 per share, above the Zacks Investment Research, Inc. consensus estimate of $1 and compared with $1.08 per share a year earlier.10d ago

CONMED Corp reported Q3 2026 net sales of $335.6 million, net income of $19.796 million and diluted EPS of $0.66, and provided FY2026 revenue guidance of $1.36 billion to $1.366 billion and EPS guidance of $4.54 to $4.61.10d ago

Similar companies

Guangdong True Health Medical Technology Development Co., Ltd.02697.HK Acotec Scientific Holdings Limited06669.HK Butterfly Network, Inc.BFLY Shanghai HeartCare Medical Technology Corporation Limited06609.HK Inspire Medical Systems, Inc.INSP PROCEPT BioRobotics CorporationPRCT Find similar companies →

Latest newsMore news →

CONMED Corp reported quarterly earnings of $1.04 per share, above the Zacks Investment Research, Inc. consensus estimate of $1 and compared with $1.08 per share a year earlier.10d ago CONMED Corp reported Q3 2026 net sales of $335.6 million, net income of $19.796 million and diluted EPS of $0.66, and provided FY2026 revenue guidance of $1.36 billion to $1.366 billion and EPS guidance of $4.54 to $4.61.10d ago